1023 related articles for article (PubMed ID: 22351071)
1. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
[TBL] [Abstract][Full Text] [Related]
2. Learning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us.
Santos AR; Kanellopoulos AK; Bagni C
Learn Mem; 2014 Oct; 21(10):543-55. PubMed ID: 25227249
[TBL] [Abstract][Full Text] [Related]
3. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
[TBL] [Abstract][Full Text] [Related]
4. Fragile X Mental Retardation Protein and Dendritic Local Translation of the Alpha Subunit of the Calcium/Calmodulin-Dependent Kinase II Messenger RNA Are Required for the Structural Plasticity Underlying Olfactory Learning.
Daroles L; Gribaudo S; Doulazmi M; Scotto-Lomassese S; Dubacq C; Mandairon N; Greer CA; Didier A; Trembleau A; Caillé I
Biol Psychiatry; 2016 Jul; 80(2):149-159. PubMed ID: 26372002
[TBL] [Abstract][Full Text] [Related]
5. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
[TBL] [Abstract][Full Text] [Related]
6. BDNF in fragile X syndrome.
Castrén ML; Castrén E
Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.
Ronesi JA; Huber KM
Sci Signal; 2008 Feb; 1(5):pe6. PubMed ID: 18272470
[TBL] [Abstract][Full Text] [Related]
8. Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse.
Filippini A; Bonini D; Lacoux C; Pacini L; Zingariello M; Sancillo L; Bosisio D; Salvi V; Mingardi J; La Via L; Zalfa F; Bagni C; Barbon A
RNA Biol; 2017 Nov; 14(11):1580-1591. PubMed ID: 28640668
[TBL] [Abstract][Full Text] [Related]
9. Synaptic vesicle dynamic changes in a model of fragile X.
Broek JAC; Lin Z; de Gruiter HM; van 't Spijker H; Haasdijk ED; Cox D; Ozcan S; van Cappellen GWA; Houtsmuller AB; Willemsen R; de Zeeuw CI; Bahn S
Mol Autism; 2016; 7():17. PubMed ID: 26933487
[TBL] [Abstract][Full Text] [Related]
10. Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons.
Tabet R; Moutin E; Becker JA; Heintz D; Fouillen L; Flatter E; Krężel W; Alunni V; Koebel P; Dembélé D; Tassone F; Bardoni B; Mandel JL; Vitale N; Muller D; Le Merrer J; Moine H
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3619-28. PubMed ID: 27233938
[TBL] [Abstract][Full Text] [Related]
11. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
[TBL] [Abstract][Full Text] [Related]
12. Fragile X syndrome: From protein function to therapy.
Bagni C; Oostra BA
Am J Med Genet A; 2013 Nov; 161A(11):2809-21. PubMed ID: 24115651
[TBL] [Abstract][Full Text] [Related]
13. microRNAs and Fragile X Syndrome.
Lin SL
Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
[TBL] [Abstract][Full Text] [Related]
14. Aberrant RNA translation in fragile X syndrome: From FMRP mechanisms to emerging therapeutic strategies.
Banerjee A; Ifrim MF; Valdez AN; Raj N; Bassell GJ
Brain Res; 2018 Aug; 1693(Pt A):24-36. PubMed ID: 29653083
[TBL] [Abstract][Full Text] [Related]
15. Expression of fragile X mental retardation-1 gene with nuclear export signal mutation changes the expression profiling of mouse cerebella immortal neuronal cell.
Hu L; Chen Y; Evers S; Shen Y
Proteomics; 2005 Oct; 5(15):3979-90. PubMed ID: 16130171
[TBL] [Abstract][Full Text] [Related]
16. Fragile X Syndrome: from molecular pathology to therapy.
Maurin T; Zongaro S; Bardoni B
Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():242-55. PubMed ID: 24462888
[TBL] [Abstract][Full Text] [Related]
17. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome.
Dictenberg JB; Swanger SA; Antar LN; Singer RH; Bassell GJ
Dev Cell; 2008 Jun; 14(6):926-39. PubMed ID: 18539120
[TBL] [Abstract][Full Text] [Related]
18. Neuron-Specific FMRP Roles in Experience-Dependent Remodeling of Olfactory Brain Innervation during an Early-Life Critical Period.
Golovin RM; Vest J; Broadie K
J Neurosci; 2021 Feb; 41(6):1218-1241. PubMed ID: 33402421
[TBL] [Abstract][Full Text] [Related]
19. The state of synapses in fragile X syndrome.
Pfeiffer BE; Huber KM
Neuroscientist; 2009 Oct; 15(5):549-67. PubMed ID: 19325170
[TBL] [Abstract][Full Text] [Related]
20. Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse.
Pacey LK; Doss L; Cifelli C; van der Kooy D; Heximer SP; Hampson DR
Mol Cell Neurosci; 2011 Mar; 46(3):563-72. PubMed ID: 21215802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
